The stock dipped 4% to Rs 3,465, extending its past two days 2% decline on the BSE. ...http://www.business-standard.com/article/markets/dr-reddys-lab-trades-weak-ahead-of-q1-results-116072500266_1.html
Markets gained momentum in late morning deals to trade near their day's high led by financials with Axis Bank paring some of its early losses post... ...http://www.rediff.com/money/report/how-the-markets-fared-on-july-25/20160725.htm
HDFC, HDFC Bank, ICICI Bank, SBI, TCS and Maruti Suzuki were top contributors to Sensex's gains while Dr Reddy's Labs fell nearly 4 percent ahead... ...http://www.moneycontrol.com/news/local-markets/sensex-inches-towards-28k-nifty-firm-hdfc-maruti-icici-lead_7104161.html
US sales in Q1 is estimated at USD 270-276 million from USD 285 million (QoQ), due to pricing pressure in drugs such as Valcyte Vidaza generic.... ...http://www.moneycontrol.com/news/result-poll/us-biz-may-drag-dr-reddys-q1-net-seen-down-27-at-456-cr_7100081.html
BHEL, SBI, HDFC, Maruti and ONGC are top gainers while Dr Reddy's, Axis Bank, Bajaj Auto, HUL and LT are losers in the Sensex. ...http://www.moneycontrol.com/news/local-markets/nifty-above-8550-dr-reddys-down-3-bhelsbi2_7103121.html
Dr Sandeep Kulshrestha is an...
Research Scientist, USA